Literature DB >> 6863921

Binding of phosphorylcholine by non-immunoglobulin molecules on mouse B cells.

M A Bach, H Kohler, D Levitt.   

Abstract

Phosphorylcholine (PC), a molecule found in the cell wall of most serotypes of pneumococcus, has been used extensively as a probe for the study of network interactions during immune responses. The frequency of B lymphocytes capable of interacting with PC has not been directly examined. We used immunofluorescence to study the binding of PC and monoclonal anti-TEPC15 anti-idiotopic antibodies to murine lymphocytes. In addition to identifying PC-specific Ig molecules, PC was bound by a non-Ig molecule on the surface of a relatively large subset of B cells; this non-Ig marker shared an idiotypic determinant with the PC-binding myeloma protein HOPC8 (H8). PC-bearing R36a pneumococci bind to a similar subset of lymphocytes. This binding is inhibited specifically by PC coupled to bovine serum albumin and also by a monoclonal anti-H8 antibody. We suggest that bacterial interaction with B cells through non-Ig molecules capable of binding a dominant antigen like PC may possess functional significance, possibly during the events that lead to antibody induction by these microorganisms.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6863921

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  In vivo polyclonal stimulation of antibody secretion by two types of bacteria.

Authors:  D Levitt; M A Bach
Journal:  Immunology       Date:  1985-08       Impact factor: 7.397

2.  Presence of phosphorylcholine on a filarial nematode protein influences immunoglobulin G subclass response to the molecule by an interleukin-10-dependent mechanism.

Authors:  K M Houston; E H Wilson; L Eyres; F Brombacher; M M Harnett; J Alexander; W Harnett
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

3.  Antibodies to phosphocholine-bearing antigens in lymphatic filariasis and changes following treatment with diethylcarbamazine.

Authors:  R B Lal; E A Ottesen
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.